Dr. Rajendra S. Baliga, MD

Dr. Baliga practices at Tampa General Hospital in Tampa, Florida, part of Tampa General Hospital.

Dr. Baliga's NPI, 1932103264, was assigned on May 23, 2005. Dr. Baliga graduated from Seth G.S. Medical College in 1995. Dr. Baliga holds Florida license ME82461.

Dr. Baliga's primary practice is Tampa General Hospital, at 1 Tampa General Cir, Tampa, FL 33606 in Hillsborough County. The practice phone is (813) 844-7000.

Dr. Baliga's primary practice is Tampa General Hospital in Tampa, Florida, part of Tampa General Hospital. Dr. Baliga is also affiliated with Sarasota Memorial Hospital - Sarasota Campus. The medical group on file is Florida Kidney Physicians. Dmand AI also links Dr. Baliga to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Baliga practices, 3 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Baliga's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Baliga is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Baliga's licenses on file in 2 states: Florida and Illinois.

Dmand AI lists acute kidney failure and chronic kidney disease among the conditions Dr. Baliga treats.

CMS data shows 1,452 Medicare services from Dr. Baliga across 9 procedure codes in 2024, for 359 Medicare patients. Medicare paid $121,883 for them.

CMS counts 359 Medicare patients who saw Dr. Baliga in 2024. The largest group is under 65, with 168 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 29% are also on Medicaid. Their average risk score is 6.87, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Baliga's median patient age at 59, with 42% women.

In 2024, Dr. Baliga wrote 1,287 Medicare Part D claims for 309 patients. 74% of them were for generic drugs. CMS names the drug for 1,074 of them, across 30 drugs with 11 or more claims each, at $328,935 in total drug cost. In 2023, CMS named 960 claims across 25 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Baliga for performance year 2024, reported as part of a group. Dr. Baliga accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 11 papers to Dr. Baliga, published from 2008 to 2025. 2008 was the busiest year, with 2. The most frequent topics are Kidney Transplantation, Graft Rejection and Graft Survival. Dr. Baliga has published most often in Am J Transplant. Dr. Baliga's most frequent co-authors are Enver Akalin, MD, Tarek Alhamad, MD and Sanjiv Anand, MD, MS.

Dmand AI links Dr. Baliga to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Viremia and Sepsis.

CMS Open Payments shows 34 general payments to Dr. Baliga from 14 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 52% of the total. Veloxis Pharmaceuticals, Inc. paid the most, $3,877.

Dmand AI lists 2 awards for Dr. Baliga, most recently CMS Stage 1 EHR in 2013.

Dr. Baliga graduated from Seth G.S. Medical College in 1995. Dr. Baliga is a member of ASN.

Dr. Baliga is in network with 19 carriers, including Aetna, Excellus BlueCross BlueShield and Elevance. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.